|
ZBTB5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.500400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.454600E-01 |
| Normal-vs-Stage2 |
6.369200E-01 |
| Normal-vs-Stage3 |
6.083600E-01 |
| Normal-vs-Stage4 |
7.661400E-01 |
| Stage1-vs-Stage2 |
9.035800E-01 |
| Stage1-vs-Stage3 |
4.760000E-01 |
| Stage1-vs-Stage4 |
6.177400E-01 |
| Stage2-vs-Stage3 |
4.598200E-01 |
| Stage2-vs-Stage4 |
5.595200E-01 |
| Stage3-vs-Stage4 |
9.367800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.305400E-01 |
| Normal-vs-AfricanAmerican |
6.022800E-01 |
| Normal-vs-Asian |
9.904500E-03 |
| Caucasian-vs-AfricanAmerican |
7.548000E-01 |
| Caucasian-vs-Asian |
1.214430E-02 |
| AfricanAmerican-vs-Asian |
8.014200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.869600E-01 |
| Normal-vs-Female |
4.954400E-01 |
| Male-vs-Female |
9.729400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.945200E-01 |
| Normal-vs-Extreme_Weight |
6.929200E-01 |
| Normal-vs-Obese |
2.311800E-01 |
| Normal-vs-Extreme_Obese |
3.658800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.781000E-01 |
| Normal_Weight-vs-Obese |
8.958000E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.039600E-01 |
| Extreme_Weight-vs-Obese |
1.531620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.756400E-01 |
| Obese-vs-Extreme_Obese |
9.541400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.533000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.597800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.578200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.446300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.584600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.941400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.625800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.464110E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.965900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.522400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.592230E-02 |
| Normal-VS-Type2 PRCC |
3.618500E-03 |
| Normal-VS-KIRP CIMP |
6.104000E-01 |
| Normal-VS-Unclassified PRCC |
2.572200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.49910000027498E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.209400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.064000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.160600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.161000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.192600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.426200E-01 |
| Normal-vs-N1 |
8.450000E-01 |
| Normal-vs-N2 |
6.144900E-03 |
| N0-vs-N1 |
5.329000E-01 |
| N0-vs-N2 |
1.883410E-01 |
| N1-vs-N2 |
5.429900E-02 |
|
|
